Haarmeyer G-S, Valtin C, Gottlieb J
Medizinische Klinik 3 (Pneumologie), Klinikum Nürnberg, Universitätsklinik der Paracelsus Medizinischen Privatuniversität, Nürnberg, Deutschland.
Klinik für Pneumologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
Pneumologie. 2021 May;75(5):360-368. doi: 10.1055/a-1341-5238. Epub 2021 Feb 23.
Long-term oxygen treatment (LTOT) is frequently used in patients with advanced pulmonary diseases and respiratory failure. Oxygen treatment influences donor lung allocation for patients and is associated with increased mortality. This study investigates oxygen therapy in lung transplantation candidates.
A retrospective study at a large German transplantation centre between 09/2011 and 01/2019 was performed. Data regarding oxygen therapy was analyzed and LTOT-indication verified by titrated blood gas analysis. The study period splits into 2 periods before and after the introduction of oxygen titration (3rd quarter of 2015). Univariate and multivariate analysis for the endpoint "admission to waiting list" was performed.
807 patients were included in the analysis, 396 in the first and 411 patients in the second period. Of those 293 patients (36.3 %) were transplanted. Six hundred thirty (78 %) patients stated using oxygen for more than 12 hours per day. After implementing oxygen titration in period 2, in 212 (57 %) of 372 patients LTOT indication could be confirmed. Titrated oxygen flow was lower in period 2 (0.5 l/min [IQR 0.0 - 2.0] versus 2 l/min [IQR 0.5 - 3.0]). In multivariate analysis oxygen flow was associated with admission to waiting list as an independent variable.
Patients referred to lung transplantation use oxygen therapy in the vast majority. Indication for LTOT should be carefully reassessed in candidates. Confirmed LTOT-indication seems to be associated with the likelihood for admission to the waiting list for lung transplantation and could therefore be a selection criterium in the future.
长期氧疗(LTOT)常用于晚期肺部疾病和呼吸衰竭患者。氧疗会影响患者的供肺分配,并与死亡率增加相关。本研究调查肺移植候选者的氧疗情况。
在德国一家大型移植中心进行了一项回顾性研究,研究时间为2011年9月至2019年1月。分析了氧疗数据,并通过滴定血气分析验证LTOT指征。研究期分为引入氧滴定前(2015年第三季度)和引入氧滴定后两个时期。对“列入等待名单”这一终点进行单因素和多因素分析。
807例患者纳入分析,第一期396例,第二期411例。其中293例(36.3%)患者接受了移植。630例(78%)患者表示每天使用氧气超过12小时。在第二期实施氧滴定后,372例患者中有212例(57%)的LTOT指征得到确认。第二期滴定氧流量较低(0.5升/分钟[四分位间距0.0 - 2.0],而第一期为2升/分钟[四分位间距0.5 - 3.0])。在多因素分析中,氧流量作为独立变量与列入等待名单相关。
转诊至肺移植的患者绝大多数使用氧疗。应仔细重新评估候选者的LTOT指征。已确认的LTOT指征似乎与列入肺移植等待名单的可能性相关,因此未来可能成为一项选择标准。